Skip Navigation



Journal of the National Cancer Institute Advance Access published online on August 28, 2007

JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djm106
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow JNCI Podcast
Right arrow All Versions of this Article:
99/17/1304    most recent
djm106v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow patientINFORMation
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Montgomery, G. H.
Right arrow Articles by Silverstein, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montgomery, G. H.
Right arrow Articles by Silverstein, J. H.
Related Collections
Right arrowEditorial about this Article
Right arrowRelated Articles in JNCI
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

ARTICLES

A Randomized Clinical Trial of a Brief Hypnosis Intervention to Control Side Effects in Breast Surgery Patients

Guy H. Montgomery, Dana H. Bovbjerg, Julie B. Schnur, Daniel David, Alisan Goldfarb, Christina R. Weltz, Clyde Schechter, Joshua Graff-Zivin, Kristin Tatrow, Donald D. Price, Jeffrey H. Silverstein

Affiliations of authors: Department of Oncological Sciences (GHM, DHB, JBS), Department of Surgery (AG, CRW), and Department of Anesthesiology Sciences (JHS), Mount Sinai School of Medicine, New York, NY; Department of Clinical Psychology and Psychotherapy, Babes-Bolyai University, Cluj-Napoca, Romania (DD); Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, NY (CS); Department of Health Policy and Management, Columbia University, New York, NY (JGZ); Department of Psychology, Good Shepherd Rehabilitation Hospital, Allentown, PA (KT); Departments of Oral and Maxillofacial Surgery and Neuroscience, University of Florida, Gainesville, FL (DDP)

Correspondence to: Guy H. Montgomery, PhD, Department of Oncological Sciences, Mount Sinai School of Medicine, Box 1130, 1 Gustave L. Levy Place, New York, NY 10029-6574 (e-mail: guy.montgomery{at}mssm.edu).

Background: Breast cancer surgery is associated with side effects, including postsurgical pain, nausea, and fatigue. We carried out a randomized clinical trial to test the hypotheses that a brief presurgery hypnosis intervention would decrease intraoperative anesthesia and analgesic use and side effects associated with breast cancer surgery and that it would be cost effective.

Methods: We randomly assigned 200 patients who were scheduled to undergo excisional breast biopsy or lumpectomy (mean age 48.5 years) to a 15-minute presurgery hypnosis session conducted by a psychologist or nondirective empathic listening (attention control). Patients were not blinded to group assignment. Intraoperative anesthesia use (i.e., of the analgesics lidocaine and fentanyl and the sedatives propofol and midazolam) was assessed. Patient-reported pain and other side effects as measured on a visual analog scale (0–100) were assessed at discharge, as was use of analgesics in the recovery room. Institutional costs and time in the operating room were assessed via chart review.

Results: Patients in the hypnosis group required less propofol (means = 64.01 versus 96.64 µg; difference = 32.63; 95% confidence interval [CI] = 3.95 to 61.30) and lidocaine (means = 24.23 versus 31.09 mL; difference = 6.86; 95% CI = 3.05 to 10.68) than patients in the control group. Patients in the hypnosis group also reported less pain intensity (means = 22.43 versus 47.83; difference = 25.40; 95% CI = 17.56 to 33.25), pain unpleasantness (means = 21.19 versus 39.05; difference = 17.86; 95% CI = 9.92 to 25.80), nausea (means = 6.57 versus 25.49; difference = 18.92; 95% CI = 12.98 to 24.87), fatigue (means = 29.47 versus 54.20; difference = 24.73; 95% CI = 16.64 to 32.83), discomfort (means = 23.01 versus 43.20; difference = 20.19; 95% CI = 12.36 to 28.02), and emotional upset (means = 8.67 versus 33.46; difference = 24.79; 95% CI = 18.56 to 31.03). No statistically significant differences were seen in the use of fentanyl, midazolam, or recovery room analgesics. Institutional costs for surgical breast cancer procedures were $8561 per patient at Mount Sinai School of Medicine. Patients in the hypnosis group cost the institution $772.71 less per patient than those in the control group (95% CI = 75.10 to 1469.89), mainly due to reduced surgical time.

Conclusions: Hypnosis was superior to attention control regarding propofol and lidocaine use; pain, nausea, fatigue, discomfort, and emotional upset at discharge; and institutional cost. Overall, the present data support the use of hypnosis with breast cancer surgery patients.



CONTEXT AND CAVEATS

Prior knowledge

Hypnosis has been shown to reduce the need for medication and postsurgical symptoms in some surgical populations, but its effectiveness in breast cancer patients undergoing surgery was not known.

Study design

Randomized trial in which use of anesthesia during surgery and patient-reported postsurgical pain and other side effects were compared in women who were randomly assigned to a brief psychologist-conducted hypnosis intervention before excisional tumor biopsy or lumpectomy or to a control (nondirected listening) session with a psychologist. Institutional costs of surgery were also compared between the groups.

Contribution

Patients in the hypnosis group required less of the analgesic lidocaine and the sedative propofol during surgery than patients in the control group; they also reported less postsurgical pain and other side effects and spent less time in surgery. Surgical costs were also lower in the hypnosis group.

Implications

The hypnosis intervention not only reduced use of anesthesia and self-reported pain but also reduced institutional costs for surgery, mainly by reducing time in the operating room.

Limitations

Patients were not blinded to their group assignment, and the effectiveness of blinding of the research and clinical staff was not formally assessed. Whether the hypnosis intervention would be effective if administered by nonpsychologists was not evaluated.

 
Manuscript received January 5, 2007; revised June 25, 2007; accepted July 11, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Find additional patient-related information at:

Hypnosis May Lower Side Effects, Costs of Breast Surgery

Editorial about this Article

The Mind Prepared: Hypnosis in Surgery
David Spiegel
J Natl Cancer Inst 2007 99: 1280-1281. [Extract] [Full Text] [PDF]

Related Articles in JNCI

Press Release: Drop in Breast Cancer Incidence Linked to Hormone Use, Not Mammograms
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]

IN THIS ISSUE
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]

Press Release: Hypnosis Reduces Pain and Costs in Breast Cancer Surgery
Liz Savage and Andrea Widener
J Natl Cancer Inst 2007 99: 1277. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
D. Spiegel
The Mind Prepared: Hypnosis in Surgery
J Natl Cancer Inst, September 5, 2007; 99(17): 1280 - 1281.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.